165 related articles for article (PubMed ID: 30712886)
1. Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer.
Zhong Y; Wang Y; Huang J; Xu X; Pan W; Gao S; Zhang Y; Su M
Pathol Res Pract; 2019 Apr; 215(4):748-754. PubMed ID: 30712886
[TBL] [Abstract][Full Text] [Related]
2. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
[TBL] [Abstract][Full Text] [Related]
3. β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway.
Wu W; Gao H; Li X; Peng S; Yu J; Liu N; Zhan G; Zhu Y; Wang K; Guo X
Cell Cycle; 2019 Jan; 18(1):46-59. PubMed ID: 30582718
[TBL] [Abstract][Full Text] [Related]
4. Luteinizing hormone receptor promotes angiogenesis in ovarian endothelial cells of Macaca fascicularis and Homo sapiens†.
Lund M; Pearson AC; Sage MAG; Duffy DM
Biol Reprod; 2023 Feb; 108(2):258-268. PubMed ID: 36214501
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing hormone/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active.
Kanamarlapudi V; Gordon UD; López Bernal A
Reprod Biomed Online; 2016 Jun; 32(6):635-41. PubMed ID: 27061682
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling.
Lazzaretti C; Secco V; Paradiso E; Sperduti S; Rutz C; Kreuchwig A; Krause G; Simoni M; Casarini L
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375708
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues].
Szajnik M; Nowak-Markwitz E; Szczepański MJ; Spaczyński M
Ginekol Pol; 2007 Dec; 78(12):939-43. PubMed ID: 18411916
[TBL] [Abstract][Full Text] [Related]
8. Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype.
Cheung J; Lokman NA; Abraham RD; Macpherson AM; Lee E; Grutzner F; Ghinea N; Oehler MK; Ricciardelli C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374698
[TBL] [Abstract][Full Text] [Related]
9. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
10. Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis.
Fowler PA; Bhattacharya S; Gromoll J; Monteiro A; O'Shaughnessy PJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4688-95. PubMed ID: 19837924
[TBL] [Abstract][Full Text] [Related]
11. Post-trigger luteinizing hormone concentration to positively predict oocyte yield in the antagonist protocol and its association with genetic variants of LHCGR.
Jin H; Yang H; Zheng J; Zhou J; Yu R
J Ovarian Res; 2023 Sep; 16(1):189. PubMed ID: 37691102
[TBL] [Abstract][Full Text] [Related]
12. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas.
Mandai M; Konishi I; Kuroda H; Fukumoto M; Komatsu T; Yamamoto S; Nanbu K; Rao CV; Mori T
Eur J Cancer; 1997 Aug; 33(9):1501-7. PubMed ID: 9337696
[TBL] [Abstract][Full Text] [Related]
13. A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies.
Banerjee S; Smallwood A; Chambers AE; Papageorghiou A; Loosfelt H; Spencer K; Campbell S; Nicolaides K
Reprod Biol Endocrinol; 2005 Jun; 3():25. PubMed ID: 15969756
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.
Lenhard M; Tsvilina A; Schumacher L; Kupka M; Ditsch N; Mayr D; Friese K; Jeschke U
BMC Cancer; 2012 Jan; 12():2. PubMed ID: 22214378
[TBL] [Abstract][Full Text] [Related]
16. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
17. Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat.
White SS; Ojeda SR
Endocrinology; 1981 Jul; 109(1):152-61. PubMed ID: 6263582
[TBL] [Abstract][Full Text] [Related]
18. Sp1 regulates steroidogenic genes and LHCGR expression in primary human luteinized granulosa cells.
Convissar S; Winston NJ; Fierro MA; Scoccia H; Zamah AM; Stocco C
J Steroid Biochem Mol Biol; 2019 Jun; 190():183-192. PubMed ID: 30954507
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
Zeng Y; Chen M; Ganesh S; Hu S; Chen H
PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768
[TBL] [Abstract][Full Text] [Related]
20. Expression of luteinizing hormone/human chorionic gonadotrophin (LH/HCG) receptor mRNA in the human ovary.
Minegishi T; Tano M; Abe Y; Nakamura K; Ibuki Y; Miyamoto K
Mol Hum Reprod; 1997 Feb; 3(2):101-7. PubMed ID: 9239715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
